Mitsuhiro Ibe
President en ZERIA PHARMACEUTICAL CO., LTD. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Mitsuhiro Ibe currently works at Tillotts Pharma AG, as Non Executive Director and Zeria Pharmaceutical Co., Ltd., as President, COO & Representative Director from 2014.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/03/2023 | 77 000 ( 0.14% ) | 1 M $ | 31/03/2024 |
Cargos activos de Mitsuhiro Ibe
Empresas | Cargo | Inicio |
---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | President | 01/06/2014 |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Mitsuhiro Ibe